Prevention of estrogen-mediated mammary carcinogenesis by mixtures of tocopherols
Prevention of estrogen-mediated mammary carcinogenesis by mixtures of tocopherols
批准号:
8369477
负责人:
Nanjoo Suh
金额:
$39.1万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2017-07-31
关键词:
AddressAnimal ModelAntioxidantsApoptosisBiological MarkersBloodBreastBreast Cancer ModelBreast Cancer PreventionBreast Cancer Prevention TrialCell LineCell ProliferationCell SurvivalClinical TrialsConflict (Psychology)DataDietDosage FormsDoseEffectivenessEstrogen ReceptorsEstrogensEvaluationFoodFutureGeneral PopulationHumanHyperplasiaIn VitroInbred ACI RatsIndividualIntervention StudiesKnowledgeMalignant NeoplasmsMammary NeoplasmsMammary TumorigenesisMammary glandMediatingMethodsMolecularMolecular Mechanisms of ActionNF-E2-related factor 2OutcomePeroxisome Proliferator-Activated ReceptorsPreventionPreventiveProtocols documentationReceptor SignalingResearchSignal PathwaySignal TransductionSystemTestingTissuesTocopherolsVegetable OilsVitamin Ealpha Tocopherolbasecancer preventioncarcinogenesisdesigndietary supplementsin vivomalignant breast neoplasmnitrosative stresspreventresponsestemtumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tocopherols are naturally occurring phenolic compounds and are the major forms of vitamin E in our body. Tocopherols exist in four forms, designated as alpha (¿), beta (¿), gamma (?), and delta (¿). Recent clinical trials with ¿-tocopherol have provided disappointing results for cancer prevention. We believe these studies were designed based on insufficient knowledge of the cancer preventive activities of the different forms of the tocopherols. There is an urgent need for investigating the activities of the
different forms, such as ?-tocopherol, the major form of vitamin E in the diet in the U.S, and for identifying molecular mechanisms and targets of tocopherols. Our recent studies demonstrate that tocopherol mixtures that are rich in ?-tocopherol (?-TmT) inhibit progression of mammary hyperplasia and induce apoptosis in vivo and in cell lines, and prevent mammary tumorigenesis in animal models of breast cancer. We hypothesize that ?- and ¿-tocopherols suppress oxidative/nitrosative stress, modulate estrogen receptor (ER) and peroxisome proliferator-activated receptor-? (PPAR?) signaling, inhibit cell proliferation and induce apoptosis, resulting in the inhibition of breast carcinogenesis. We propose to test our hypotheses and achieve our objectives by addressing four Specific Aims: 1. Investigate the dose-dependent inhibitory effects of a naturally occurring tocopherol mixture ?-TmT on estrogen-induced hyperplasia and tumorigenesis in the ACI rat model of mammary cancer. 2. Purify individual tocopherols (T), ?-T, ¿-T, and ¿-T, and determine their cancer preventive activities in estrogen-mediated mammary tumorigenesis in ACI rats. 3. Elucidate the molecular mechanisms of action of tocopherols in modulating estrogen receptors (ERs) and PPAR?, resulting in suppressing cell proliferation and cell survival in cell lines. 4. Investigate the molecular mechanisms of action of tocopherols in suppressing oxidative/nitrosative stress, and the possible involvement of NF-E2 related factor-2 (Nrf2). Tocopherols are commonly occurring in vegetable oils and readily available as dietary supplements. Understanding the effects of naturally occurring tocopherol mixtures and individual tocopherols and identifying the key mechanisms of action is critical for their use in prevention of cancer. Our data will be valuable for future studies in selecting the optimal form or
mixtures of tocopherols and in designing better protocols for human breast cancer prevention trials. This study will provide the first comprehensive evaluation of tocopherol mixtures and individual tocopherols for the prevention of breast cancer.
PUBLIC HEALTH RELEVANCE: Tocopherols have been examined for many years for their anti-oxidant activities as well as cancer preventive effects, but recent large-scale clinical trial with alpha-tocopherol provided conflicting results to general public. We propose to determine the effectiveness of naturally occurring tocopherols, in individual forms and mixtures, for the prevention of breast cancer, and to investigate their molecular mechanisms of action. Understanding the effects of naturally occurring tocopherol mixtures and individual tocopherols and identifying the key mechanisms of action are critical for their use in the prevention of cancer
in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel strategy targeting TP63 for breast cancer prevention
-
批准号:10608150
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2022
-
负责人:Nanjoo Suh
-
依托单位:
A novel strategy targeting TP63 for breast cancer prevention
-
批准号:10435255
-
项目类别:
-
资助金额:$7.85万
-
财政年份:2022
-
负责人:Nanjoo Suh
-
依托单位:
Prevention of estrogen-mediated mammary carcinogenesis by mixtures of tocopherols
-
批准号:8518243
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2012
-
负责人:Nanjoo Suh
-
依托单位:
Prevention of estrogen-mediated mammary carcinogenesis by mixtures of tocopherols
-
批准号:8704881
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2012
-
负责人:Nanjoo Suh
-
依托单位:
Tocopherol-mediated inhibition of breast carcinogenesis
-
批准号:7747368
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2009
-
负责人:Nanjoo Suh
-
依托单位:
Tocopherol-mediated inhibition of breast carcinogenesis
-
批准号:7880191
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2009
-
负责人:Nanjoo Suh
-
依托单位:
Inhibition of breast cancer progression by vitamin D analogs and triterpenoids
-
批准号:8231508
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2008
-
负责人:Nanjoo Suh
-
依托单位:
Inhibition of breast cancer progression by vitamin D analogs and triterpenoids
-
批准号:7768474
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2008
-
负责人:Nanjoo Suh
-
依托单位:
Inhibition of breast cancer progression by vitamin D analogs and triterpenoids
-
批准号:7845227
-
项目类别:
-
资助金额:$1.72万
-
财政年份:2008
-
负责人:Nanjoo Suh
-
依托单位:
Inhibition of breast cancer progression by vitamin D analogs and triterpenoids
-
批准号:8037694
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2008
-
负责人:Nanjoo Suh
-
依托单位:
Inhibition of breast cancer progression by vitamin D analogs and triterpenoids
-
批准号:7366937
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2008
-
负责人:Nanjoo Suh
-
依托单位:
Inhibition of breast cancer progression by vitamin D analogs and triterpenoids
-
批准号:7618408
-
项目类别:
-
资助金额:$24.99万
-
财政年份:2008
-
负责人:Nanjoo Suh
-
依托单位:
Chemoprevention of cancer by nuclear receptor ligands
-
批准号:6878390
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2004
-
负责人:Nanjoo Suh
-
依托单位:
Chemoprevention of cancer by nuclear receptor ligands
-
批准号:6951896
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2004
-
负责人:Nanjoo Suh
-
依托单位:
Mechanism Based Chemoprevention of Cancer
-
批准号:6596439
-
项目类别:
-
资助金额:$2.32万
-
财政年份:2003
-
负责人:Nanjoo Suh
-
依托单位:
Mechanism Based Chemoprevention of Cancer
-
批准号:6893992
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2003
-
负责人:Nanjoo Suh
-
依托单位:
Mechanism Based Chemoprevention of Cancer
-
批准号:6793047
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2003
-
负责人:Nanjoo Suh
-
依托单位:
Mechanism Based Chemoprevention of Cancer
-
批准号:6778183
-
项目类别:
-
资助金额:$15.88万
-
财政年份:2003
-
负责人:Nanjoo Suh
-
依托单位:
COX-2 Inhibitor and N-3PUFA in Colon Cancer Prevention
-
批准号:7230480
-
项目类别:
-
资助金额:$27.54万
-
财政年份:1993
-
负责人:Nanjoo Suh
-
依托单位:
海外基金